Our research reveals that TP53 acts as a transcription factor to promote the expression ofmiR‐3647‐5p, while up‐regulated miR‐3647‐5p targets AGR2, inhibiting cervical cancer cell proliferation and promoting apoptosis. The gene discussed is TP53; the disease is cervical cancer.